Effect of Flex-a-New on Osteoarthritis of the Knee
1 other identifier
interventional
80
1 country
1
Brief Summary
comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 21, 2006
CompletedFirst Posted
Study publicly available on registry
February 22, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedFebruary 22, 2006
February 1, 2006
February 21, 2006
February 21, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
KOOS
Secondary Outcomes (1)
VAS KSS
Interventions
Eligibility Criteria
You may qualify if:
- knee osteoarthritis grade 1 to 3 -
You may not qualify if:
- ischemic heart disease with CHF -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rabin Medical Center
Petah Tikwa, 49372, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
dror robinson
Rabin Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 21, 2006
First Posted
February 22, 2006
Study Start
January 1, 2006
Study Completion
December 1, 2007
Last Updated
February 22, 2006
Record last verified: 2006-02